BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15375434)

  • 1. Telomerase catalytic subunit in laryngeal carcinogenesis--an immunohistochemical study.
    Luzar B; Poljak M; Gale N
    Mod Pathol; 2005 Mar; 18(3):406-11. PubMed ID: 15375434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase reactivation is an early event in laryngeal carcinogenesis.
    Luzar B; Poljak M; Marin IJ; Gale N
    Mod Pathol; 2003 Sep; 16(9):841-8. PubMed ID: 13679446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human telomerase catalytic subunit gene re-expression is an early event in oral carcinogenesis.
    Luzar B; Poljak M; Marin IJ; Eberlinc A; Klopcic U; Gale N
    Histopathology; 2004 Jul; 45(1):13-9. PubMed ID: 15228439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative measurement of telomerase catalytic subunit (hTERT) mRNA in laryngeal squamous cell carcinomas.
    Luzar B; Poljak M; Marin IJ; Fischinger J; Gale N
    Anticancer Res; 2001; 21(6A):4011-5. PubMed ID: 11911285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 expression and clinical parameters in laryngeal squamous cell carcinoma, vocal fold nodule, and laryngeal atypical hyperplasia.
    Sayar C; Sayar H; Özdemir S; Selçuk T; Görgülü O; Akbaş Y; Kemal Olgun M
    Head Neck; 2013 Jan; 35(1):52-6. PubMed ID: 22247036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human telomerase catalytic protein in gallbladder carcinogenesis.
    Luzar B; Poljak M; Cör A; Klopcic U; Ferlan-Marolt V
    J Clin Pathol; 2005 Aug; 58(8):820-5. PubMed ID: 16049283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric analysis of Ki-67 and p16 expression in laryngeal precursor lesions.
    Pavlovic B; Djukic V; Milovanovic J; Tomanovic N; Milovanovic A; Trivic A
    Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1405-10. PubMed ID: 23408022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Telomerase hTRT mRNA expression in oral squamous cell carcinogenesis].
    Zhang L; Zhang W; Liu Z
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Nov; 17(4):307-9. PubMed ID: 12539372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human telomerase reverse transcriptase mRNA in esophageal cancers and precancerous lesions.
    Amioka T; Kitadai Y; Hiyama T; Tanaka S; Yoshihara M; Haruma K; Chayama K
    Oncol Rep; 2004 Jan; 11(1):51-5. PubMed ID: 14654902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase hTR and hTRT gene expression in oral precancerous lesions and squamous cell carcinomas.
    Zhang L; Zhang W
    Chin J Dent Res; 1999 May; 2(2):43-8. PubMed ID: 10863406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor, c-erbB-2 and p53 overexpressions in epithelial hyperplastic lesions of the larynx.
    Gale N; Zidar N; Kambic V; Poljak M; Cör A
    Acta Otolaryngol Suppl; 1997; 527():105-10. PubMed ID: 9197495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human telomerase RNA component (hTERC) gene amplification detected by FISH in precancerous lesions and carcinoma of the larynx.
    Liu Y; Dong XL; Tian C; Liu HG
    Diagn Pathol; 2012 Mar; 7():34. PubMed ID: 22463766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx.
    Zidar N; Gale N; Cör A; Kambic V
    J Laryngol Otol; 1996 May; 110(5):440-5. PubMed ID: 8762312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase catalytic subunit gene expression does not influence survival of patients with squamous cell carcinoma of the larynx and hypopharynx: a case-control study.
    Luzar B; Poljak M; Fischinger J; Klopcic U; Gale N
    J Laryngol Otol; 2005 Nov; 119(11):917-21. PubMed ID: 16354348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Ljubljana classification of epithelial hyperplastic laryngeal lesions: a morphometric evaluation of nuclear pleomorphism].
    Serio G; Gale N; Pennella A; Dalena AM; Giardina C; Valente T; Lettini T; Ricco R; Resta L
    Pathologica; 2002 Dec; 94(6):290-8. PubMed ID: 12540992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased telomerase activity and elevated hTERT mRNA expression during multistage carcinogenesis of squamous cell carcinoma of the lung.
    Shibuya K; Fujisawa T; Hoshino H; Baba M; Saitoh Y; Iizasa T; Sekine Y; Suzuki M; Hiroshima K; Ohwada H
    Cancer; 2001 Aug; 92(4):849-55. PubMed ID: 11550157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
    Li YR; Wu JM; Wang L; Huang X; Shi J; Hu LH
    Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Lublańska classification of precancerous lesions of the larynx].
    Golusiński W; Kaczmarek JP; Kaczmarek J; Biczysko W; Kedzia D
    Otolaryngol Pol; 2001; 55(1):69-73. PubMed ID: 11355482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of epidermal growth factor receptor in laryngeal squamous cell carcinomas.
    Christensen ME; Therkildsen MH; Hansen BL; Hansen GN; Bretlau P
    Acta Otolaryngol; 1992; 112(4):734-8. PubMed ID: 1442018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative morphometry of squamous cell hyperplasia of the larynx.
    Olde Kalter P; Lubsen H; Delemarre JF; Alons CL; Veldhuizen RW; Meyer CJ; Snow GB
    J Clin Pathol; 1985 May; 38(5):489-95. PubMed ID: 3889066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.